Eli Lilly now sells Zepbound, its tirzepatide obesity drug, directly to consumers for $349 or $499 per month, depending on the dose. But the deal is cash only, and the medication comes in a single-dose vial, not an injector pen. That’s still too high of a price for Melanie — double what she’s currently paying […]